A unique remote monitoring and
predictive medicine solution for your COPD patients

Discover our solution

of COPD exacerbations are detected approximately 4.4¹ days before they occur thanks to

COPD, a major public health issue

Chronic Obstructive Pulmonary Disease (COPD) is a condition characterized by the progressive deterioration of the respiratory system due to airway obstruction. 

Discover our solution

million

COPD patients in Europe²

%

of patients hospitalized after a first exacerbation are readmitted within 30 days³

billion €

The annual cost of COPD in Europe, including 29 billion related to exacerbations⁴

With millions of patients affected and a significant impact on hospitalizations and healthcare costs, the management of COPD is a major issue. 

Bora care®, towards preventive management of COPD exacerbations

Our clinically validated predictive remote monitoring solution enables continuous at-home follow-up for patients with chronic respiratory failure.  

By detecting the risk of exacerbation early through our BVS³ score, Bora care® supports preventive and personalized care, helping improve patients’ quality of life. 

1. Patient remotely monitored at home

2. Predictive BVS³ score calculated

3. Optimized care management

Benefits for every stakeholder in the care pathway

Less hospitalizations, lower healthcare costs

Thanks to our predictive BVS³ score, early identification of exacerbation risks helps reduce hospital admissions and associated healthcare expenses.

Early intervention made possible

Thanks to data transmitted via the Bora connect® platform, care teams can act at the right time — before symptoms worsen — by adjusting treatment proactively.

A smoother, more coordinated care pathway

Bora connect® enhances therapeutic follow-up and facilitates collaboration among care teams, ultimately improving the efficiency and fluidity of patient care pathways.

Request a demo

An international scientific council of excellence

Our international scientific council plays a key role in the ongoing development of our solution.  

Their expertise ensures an evidence-based approach rooted in best clinical practices, continuously enhancing the relevance and effectiveness of Bora care® for healthcare professionals. This enables more personalized and adaptive care for COPD patients by integrating Bora care® into existing care pathways.

Gérard Criner, MD President

Temple University School of Medicine, Philadelphia, Pennsylvania, USA

Alvar Agusti, MD

Respiratory Institute, Hospital Clinic, IDIBAPS, Univ. Barcelona Spain

Professor Nicolas Roche

Head of the Pulmonology Department, Cochin Hospital (APHP)

Mars Miravitlles, MD

Vice-president of the European Respiratory Society (ERS) 2024-2025

Bartolome Celli​, MD

Professor of Medicine at Harvard Medical School​

Claus Vogelmeier, MD

Chair University of Marburg​, Germany​
Chair science commitee GOLD​

Professor John Hurst​

Vice Dean (International) Faculty of Medical Sciences University College, London

A certified and trusted medical solution

Class IIa
medical device
Clinically validated
Certified in compliance with the ANS standards
GDPR-compliant solution

Our health data is hosted in HDS-certified environments to ensure the highest level of security. Our goal? To provide patients and healthcare professionals with a reliable, compliant, and secure solution 

Biosency, advancing health through innovation

6 patent families
14 international scientific publications
8 clinical trials demonstrating clinical benefits
+500k days of remote monitoring
Learn more

Contact us

Are you a healthcare professional interested in learning more about our Bora care® solution?

By submitting this form, you agree that BIOSENCY may process your personal data in order to respond to your request. Your data is processed on the basis of our legitimate interest in providing you with a response. Your contact information may also be used for marketing purposes. To learn more about how your data is handled and how to exercise your rights — including how to object to marketing communications — please refer to our Privacy Policy by clicking here.

¹Result of the E-Meuse study, presented at the European Respiratory Society (ERS) 2024 congress
²The economic and health burden of COPD in Western Europe: forecasting through 2050, Elroy Boers, Angier Allen, Meredith Barrett, 2023
³ Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis, JS Alqahtani, CM Njoku, B. Bereznicki, et al., 2020
⁴Global Burden of Chronic Obstructive Pulmonary Disease Through 2050, Elroy Boers, PhD1; Meredith Barrett, PhD2; Jason G. Su, PhD3; et al, 2023